GLAND PHARMA
|
The Current P/E Ratio of GLAND PHARMA is 39.98.
Share Price | ₹1,868.6 | Sep 08,2025 |
Market Cap | ₹30,794.5 Cr | |
Earnings-TTM | ₹770.2 Cr | TTM-Consolidated Results |
Price/Earnings | 39.98x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of GLAND PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹30,794.5 Cr] as on Sep 08,2025
(/) Earnings [ ₹770.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 39.98x ]
Thus, for GLAND PHARMA , the investors are currently willing to pay 39.98 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GLAND PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GLAND PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of GLAND PHARMA
PE Ratio Performance Analysis for GLAND PHARMA
- GLAND PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 37.71x.
- GLAND PHARMA 's operated at median p/e ratio of 39.27x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAND PHARMA 's p/e ratio peaked in Mar2022 at 44.33x.
- GLAND PHARMA 's p/e ratio hit its five-year low in Mar2023 of 26.75x.
How does GLAND PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
GLAND PHARMA | 770.25 | 39.98 | 30,794.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 36.42 | 379,191.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 69.37 | 159,973.0 |
CIPLA LTD | 5,406.81 | 23.03 | 124,507.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.03 | 122,175.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.22 | 104,355.0 |
MANKIND PHARMA LTD | 1,905.51 | 55.86 | 106,434.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.89 | 101,544.0 |
LUPIN LTD | 3,722.18 | 23.89 | 88,934.7 |
AUROBINDO PHARMA LTD | 3,417.93 | 17.68 | 60,417.9 |
ABBOTT INDIA LTD | 1,452.29 | 45.33 | 65,829.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GLAND PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.68x |
Max industry PE | 69.37x |
Median industry PE | 36.42x |
Average industry PE | 37.52x |
You may also like the below Video Courses